Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
15 June 2021 | Story Ruan Bruwer | Photo Supplied
Dougie Heymans
Dougie Heymans was the Head of Rugby at the University of the Free State until his passing.

A Shimla great, a passionate rugby and family man, and a dream colleague are just some of the descriptions of how Dougie Heymans will be remembered.

Heymans, Assistant Director: KovsieSport and Head of Rugby, passed away on Monday due to the COVID-19 disease. He was 58.

He will leave a massive legacy in his capacity as rugby administrator, said DB Prinsloo, Director of KovsieSport. “Dougie was so precise in his work. He had a huge work ethic. Everything he did was textbook stuff. He is going to be missed immensely.”

According to Prinsloo, messages of condolence have been pouring in from far and wide. One of many was from former Protea cricket great, Allan Donald, nowadays the head coach of the Knights cricket team.
“It is indeed a shock to the entire sporting world. I knew Dougie very well, his involvement with varsity rugby, but also rugby in the Free State, made a huge impact on sports. This is a huge loss not only for the Cheetahs, but also Bloemfontein and the entire region. We sadly lost a legend,” he said.

Heymans played for the Shimlas between 1989 and 1994 and went on to represent the Free State in 154 matches until 2001.In 2009, he started working for the University of the Free State. He was the man in charge of Varsity Cup matches at Shimla Park.
“They say no one is irreplaceable, but it is going to be tough to follow in his massive footsteps. It is very hard not having him around anymore. He was a fantastic colleague,” Prinsloo said.

Former Shimla and Springbok, Toks van der Linde, who played with and against Heymans, said he had lost a great friend. “He was more than a friend, like a brother to us younger guys. RIP big brother, we are going to miss you.”

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept